How Pfizer management outplayed activist investor Starboard
The push to replace Albert Bourla as Pfizer’s CEO drew attention from the pharma industry but was soon derailed by several events.
Vifor Pharma offers £23m to NHS to resolve CMA investigation
China NMPA approves Santhera’s DMD treatment therapy
Meitheal gains US commercial rights for CABP treatment therapy
Sanofi’s combo vaccines gain FDA fast track designation
Flu vaccine strategy on the line as new US leaders anticipated to take charge
Analysis
View More
Themes
View MoreNobel laureates ‘strongly urge’ Senate to oppose confirmation of RFK Jr
In the letter, 77 Nobel Prize winners argue that appointing RFK as Secretary of HHS would put the US public’s health in jeopardy.
More themes
Data Insights
View MoreCell & gene therapy: the leading companies in recombinant AAV gene therapy revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
FDA shares new draft guidance for accelerated approval
Merus’ Bizengri granted FDA accelerated approval to treat NRG1+ cancers
Trump 2.0 could see a rise in biopharmaceutical M&A deals
EMA launches ESMP for better management of drug shortages in EU